Cardiology (all articles)
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK.
29 Aug, 2022 | 12:11h | UTCAutoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK – The Lancet (free registration required)
Commentary: Population-based study: Autoimmune disorders increase risk of cardiovascular disease – MedicalXpress
Network Meta-Analysis | Antithrombotic therapy for symptomatic peripheral arterial disease.
26 Aug, 2022 | 13:28h | UTC
RCT | Self-measurement of blood pressure with a standard device is not enhanced by the use of a connected smartphone application.
26 Aug, 2022 | 13:29h | UTCEffectiveness of Standard vs Enhanced Self-measurement of Blood Pressure Paired With a Connected Smartphone Application: A Randomized Clinical Trial – JAMA Internal Medicine (link to abstract – $ for full-text)
News Release: For Checking Blood Pressure at Home, Basic Cuffs Are Just as Good – UC San Francisco
Commentary: App-enabled device no better than standard device for self-measuring blood pressure – ACP Internist
Commentary on Twitter
Monitoring #bloodpressure at home may help with #bloodpressurecontrol, but using an enhanced device pairing with a smartphone application appears to be no more effective than using a standard device. https://t.co/h6zREImCNv #Research pic.twitter.com/T1zWDlp2pC
— JAMA Internal Medicine (@JAMAInternalMed) August 15, 2022
Review | Incremental value of polygenic risk scores in primary prevention of coronary heart disease.
26 Aug, 2022 | 13:26h | UTCIncremental Value of Polygenic Risk Scores in Primary Prevention of Coronary Heart Disease: A Review – JAMA Internal Medicine (free for a limited period)
Related:
Cohort Study | Polygenic risk, midlife life’s simple 7, and lifetime risk of stroke.
AHA Scientific Statement | Polygenic risk scores for cardiovascular disease.
Cohort Study: A polygenic risk score may improve risk stratification of coronary artery disease.
Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.
Secondary analysis of a RCT | Effects of Empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure.
26 Aug, 2022 | 13:24h | UTCCommentary: Empagliflozin Offers Clinical Benefit in Heart Failure – HealthDay
Original Study: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial – Nature Medicine
Expert Analysis | Clinical applications of cardiac magnetic resonance imaging in pericardial diseases.
25 Aug, 2022 | 11:59h | UTCRelated: Case Series: Cardiac magnetic resonance in the assessment of pericardial abnormalities.
Observational study suggests Hydroxychloroquine is associated with increased risk of cardiovascular events compared to Methotrexate in patients with heart failure.
25 Aug, 2022 | 11:56h | UTCCardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Editorial: Hydroxychloroquine: Heart-Throb No More? – Journal of the American College of Cardiology
Commentary: Caution needed with hydroxychloroquine use in older RA patients with heart failure – medwire News
Vasospastic angina: a contemporary review of its pathophysiology, diagnosis and management.
25 Aug, 2022 | 11:53h | UTC
Commentary on Twitter
Almost 50% of angina pts have non obstructive CAD on cath: 3 types of ANOCA & each has its’ own Rx:
🫀Coronary micro vascular dz B blockers
🫀Coronary endothelial dysfunction (? Rx)
🫀Coronary vasospasm (Ca channel blockers/nitrates) @minissianm https://t.co/zJjhEDAs0K pic.twitter.com/zxDjDoM6ru— Ritu Thamman MD (@iamritu) August 20, 2022
USPSTF Recommendation Statement | Statin use for the primary prevention of cardiovascular disease in adults.
24 Aug, 2022 | 14:21h | UTCEditorials:
Author Interview: USPSTF Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults – JAMA
Patient Page: Statins for the Prevention of Cardiovascular Disease – JAMA
Commentary: Latest statins guidance keeps more conservative approach to preventing first stroke or heart attack – CNN
Long-term results of a RCT | Vasopressin and methylprednisolone did not improve outcomes in patients with in-hospital cardiac arrest.
24 Aug, 2022 | 14:15h | UTC
Position Statement | Chronic kidney disease as cardiovascular risk factor in routine clinical practice.
24 Aug, 2022 | 14:14h | UTC
Secondary analysis of a RCT | Early rhythm control in patients with atrial fibrillation and high comorbidity burden.
24 Aug, 2022 | 14:11h | UTCEarly Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden – Circulation
Commentary on Twitter
#OriginalResearch: In #EAST_AFNET4, substudy of patients w/ CHA2DS2VASC4 >=4 had decreased composite efficacy outcome of lower CV death, CVA or HF/ACS hospitalization w/ rhythm control, but not in patients with lower como… @AndreasRillig @AndreasMetzner7 https://t.co/izES0WodVQ pic.twitter.com/DVyfWsUsOx
— Circulation (@CircAHA) August 17, 2022
Podcast | USPSTF Update: aspirin for primary prevention of cardiovascular disease.
24 Aug, 2022 | 14:05h | UTC#347 USPSTF Update: Aspirin for Primary Prevention of CVD – The Curbsiders
Related Guideline: USPSTF Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease.
Related Randomized Trials:
Randomized Trial: Aspirin for Primary Prevention of Cardiovascular Disease
Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes
Randomized Trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
Related Meta-Analysis:
Meta-Analysis: Efficacy and Safety of Aspirin for Primary Prevention of Cardiovascular Events
Related Opinions:
Aspirin for Primary Prevention: Is This the End of the Road?
Evidence evolving on aspirin as prevention – ACP Internist
Risk of myocarditis after sequential doses of COVID-19 vaccine vs. after SARS-CoV-2 infection by age and sex.
23 Aug, 2022 | 13:25h | UTCNews Release: Myocarditis risk significantly higher after COVID-19 infection vs. after a COVID-19 vaccine – Circulation
Cohort Study | Patients with bicuspid aortic stenosis were younger, had worse perioperative left ventricular function, and increased risk of postoperative heart failure compared to patients with tricuspid aortic stenosis.
23 Aug, 2022 | 12:54h | UTC
AHA Scientific Statement | Cardiovascular effects of home dialysis therapies.
22 Aug, 2022 | 12:24h | UTCTop Things to Know: CV Effects of Home Dialysis Therapies – American Heart Association
Commentaries:
AHA Urges More Home-Based Dialysis in Advanced Kidney Failure – TCTMD
Commentary on Twitter (thread – click for more)
https://twitter.com/bourneauguste/status/1559172680087228416
RCT | Effectiveness of an intervention for reducing sitting time and improving health in office workers.
22 Aug, 2022 | 12:19h | UTCEditorial: The importance of sitting less and moving more – The BMJ
News Release: Standing desks alongside other measures cut office workers’ sitting time by an hour a day – BMJ Newsroom
Commentary: SMART Work and Life Intervention Reduces Sitting Time for Office Workers – HealthDay
Commentary on Twitter
Using a standing desk alongside a package of other measures to encourage office workers to sit less and move more, reduced sitting time by about an hour a day over one year, finds a trial published in @bmj_latest today https://t.co/uxaDWnp5WB
— The BMJ (@bmj_latest) August 18, 2022
Cross-Sectional Study | Hypertension common among poorest, least educated around the world.
22 Aug, 2022 | 12:14h | UTCThe Association of Socioeconomic Status With Hypertension in 76 Low- and Middle-Income Countries – Journal of the American College of Cardiology (link to abstract – $ for full-text)
News Release: Hypertension Common Among Poorest, Least Educated Around the World – American College of Cardiology
Commentary: Hypertension Common Among Poorest, Least Educated Globally – HealthDay
Commentary on Twitter
#HTN is a common condition in low- & middle-income countries. As countries develop economically, these groups may experience a greater #hypertension prevalence relative to those w/ ⬆️ socioeconomic status. Read more on this important work now out in #JACC: https://t.co/sOzb1aWRvk pic.twitter.com/w00raCmuCW
— JACC Journals (@JACCJournals) August 16, 2022
Review | Advances in imaging and targeted therapies for recurrent pericarditis.
22 Aug, 2022 | 12:06h | UTCAdvances in Imaging and Targeted Therapies for Recurrent Pericarditis: A Review – JAMA Cardiology (free for a limited period)
Videos:
Transthoracic Echocardiogram Showing Signs of Constrictive Physiology – JAMA
Cardiac Magnetic Resonance Showing Signs of Constrictive Physiology – JAMA
Cardiac Magnetic Resonance Finding in Constrictive Pericarditis – JAMA
Commentary on Twitter
Much is new in the management of recurrent pericarditis after the 2015 @escardio guidelines. Advances in CMR and IL-inhibitors have led to a paradigm shift in the management of this chronic debilitating disease. A state-of-the-art algorithm is proposed. https://t.co/7mdyYZ2BXS
— JAMA Cardiology (@JAMACardio) August 19, 2022
Review | Left atrial appendage occlusion, a misnomer?
22 Aug, 2022 | 12:01h | UTCLeft Atrial Appendage Occlusion, A Misnomer? – Mayo Clinic Proceedings
Review | Systemic lupus erythematosus and cardiovascular disease.
22 Aug, 2022 | 12:02h | UTCSystemic lupus erythematosus and cardiovascular disease – Journal of Internal Medicine
AHA Scientific Statement outlines the most common symptoms of 6 cardiovascular diseases.
19 Aug, 2022 | 16:19h | UTCNews Release: Report outlines most common symptoms of 6 cardiovascular diseases – American Heart Association
Top Things to Know: State of the Science: The Relevance of Symptoms in CVD and Research – American Heart Association
Cohort Study | Aldosterone linked to increased risk of chronic kidney disease progression and end-stage kidney disease.
19 Aug, 2022 | 16:09h | UTCOriginal Study: Aldosterone in chronic kidney disease and renal outcomes – European Heart Journal
Editorial: Aldosterone excess and cardiorenal risk: more common than appreciated – European Heart Journal
Commentary on Twitter
https://twitter.com/ESC_Journals/status/1556898902258991104
M-A | Performance of confirmatory tests for diagnosing primary aldosteronism.
18 Aug, 2022 | 12:54h | UTC
Commentary on Twitter
https://twitter.com/HyperAHA/status/1559624529869160448
Modeling Study | Reducing daily salt intake in China by 1 g could prevent almost 9 million cardiovascular events by 2030.
18 Aug, 2022 | 12:42h | UTCNews Release: 1 g cut in daily salt intake could ward off nearly 9 million cases of stroke/heart disease in China – BMJ Newsroom